undamentalytics Newsletter
Sign in

Primerica, Inc. (PRI) stock

Add to watchlist

Add holding +

NYSE: PRI NYSE Life & Health Insurance Next results ~November 4, 2026

Primerica, Inc. is a US-listed company in the life & health insurance industry. Its financial year ends in December.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 5 selling0 purchases and 11 sales by directors and officers, last 12 monthsInsider trades
  • Funds247 adding, 223 cuttingOf 59 active managers that changed their stake, 32 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Primerica files

Where Primerica stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $3.43bn, up 8.6% on a year earlier, faster than 6.4% a quarter earlier. The diluted share count is down 4.7% on a year earlier, which lifts each remaining share.

Our model value for Primerica is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

Primerica, Inc.'s trailing-twelve-month revenue grew 8.6% year on year, with a free-cash-flow margin of 25.5%.

Current signal Share count shrinking (buybacks): Diluted shares outstanding fell 4.7% year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Strong cash generation. 25.5% of revenue turned into free cash flow.
  • Shrinking share count. Diluted shares fell 4.7% in a year, so each share owns more of the business.
  • Net cash. Cash exceeds long-term debt by $0.6bn.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Results due soon. Results are expected around 4 November; the share price can move sharply on the day.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
$6.41 against an average estimate of $6.01: beat by 6.6%
Revenue
$865m, up 9.0% on a year earlier
Share reaction
+2.6% in the first session after the results on August 5, 2026, against -0.4% for the S&P 500
Next report
November 4, 2026; average EPS estimate $6.38

Primerica's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.9%
  • 1 week+2.4%
  • 1 month+2.9%
  • This year+11.2%
  • 1 year+11.0%
  • 5 years+72.4%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.4B
Net margin
23.2%
EPS (TTM, diluted)
$24.95

Growth

Revenue growth
+8.6%
Change in growth rate
+2.2 pts
Share count change
−4.7%

Earnings

Last results
August 5, 2026
Next results (est.)
November 4, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Announcement
  3. Announcement
  4. Results
  5. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Primerica, Inc. valuation models and calculator

No model value for Primerica, Inc. at the moment. Current status: data-quality checks not passed. Available reported financials are shown below.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Primerica, Inc. as an insurer, with every model that fits that kind of business. Cost of equity 8.8%: the 10-year Treasury yield (4.9%) plus a beta of 0.85 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Price-to-book vs return on equity (peers) The price-to-book that peers with this return on equity trade on, from a line fitted across peers. — Does not apply: This model is withheld pending its input or assumption review.
Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. ~$0.4 ~$57–$170 Left out: out of range vs price (0.00x)
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$180 ~$170–$260 Included
Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. — Does not apply: This model is withheld pending its input or assumption review.
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Primerica, Inc. with life and health insurers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

87 /100

Strong moat

How hard Primerica's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Net income has been a median 3.1% of total assets over 10 years.

  • Durability 15 / 20

    Net margin has been a median 17.8%; its worst year was 14.4%.

  • Discipline 20 / 20

    The diluted share count fell 19.6% over five years; stock-based pay has been a median 0.8% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (92 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, after the close. Analysts expect revenue of $892m and EPS of $6.38 (range $6.26 to $6.47) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $25.27 +10% $3.5bn +7%
Next $27.22 +8% $3.7bn +5%

Next year's EPS estimate has moved +2.1% in 90 days, across 8 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +2.7% on 90 days ago. In the last 30 days, 1 analyst raised Primerica, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Primerica, Inc., last 90 days
$24.00 $25.00 $26.00 $27.00 $28.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $24.60 Current fiscal year, 60 days ago: $24.97 Current fiscal year, 30 days ago: $25.24 Current fiscal year, 7 days ago: $25.27 Current fiscal year, Now: $25.27 $25.27 Next fiscal year, 90 days ago: $26.67 Next fiscal year, 60 days ago: $26.99 Next fiscal year, 30 days ago: $27.17 Next fiscal year, 7 days ago: $27.17 Next fiscal year, Now: $27.22 $27.22

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $24.60$26.67
60 days ago $24.97$26.99
30 days ago $25.24$27.17
7 days ago $25.27$27.17
Now $25.27$27.22

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $6.01 $6.41 +6.6%
Mar 2026 $5.48 $5.96 +8.7%
Dec 2025 $5.68 $6.13 +8.0%
Sept 2025 $5.54 $6.33 +14.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 5, 2026

No numeric guidance in Primerica, Inc.'s latest earnings release (filed August 5, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

8 analysts, Oct 2026
Buy225%
Hold675%
Sell00%

Monthly trend

  1. Oct 2026268
  2. Sep 2026268
  3. Aug 2026358

Counts of recommendations published by analysts covering Primerica, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
5.8%
of tradable shares
Days to cover
6.66
at average volume
Short interest, 1 month
+12%
to October 15, 2026
Held by institutions
97%
of shares
Held by insiders
0.5%
of shares
Employees
2,301
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +11.0%

$255.51 on October 31, 2025 to $283.52

ThenNowEffect
Revenue (last 12 months) $3.2bn $3.4bn +8.6%
Net margin 22.4% 23.2% +3.3%
P/E multiple 12.1x 11.4x −5.7%
Share count 33m 32m +4.9%

Biggest factor: revenue.

Last 3 years +44.7%

$195.87 on November 3, 2023 to $283.52

ThenNowEffect
Revenue (last 12 months) $2.6bn $3.4bn +29.9%
Net margin 18.9% 23.2% +22.7%
P/E multiple 14.5x 11.4x −21.6%
Share count 37m 32m +15.9%

Biggest factor: revenue.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
PRI+16%−6%+47%+34%−3%+11%
Industry peers (median)+20%−3%+19%+26%+11%+15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
PRI75%42%58%83%58%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
PRI−19%−29%−18%−18%−17%−16%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 3, 2015: 55% from December 16, 2019 to March 20, 2020. Getting back needed a 120% gain, reached on November 24, 2020, 249 days after the low.

Price behaviour

52-week range
$243.52 – $325.10
From 52-week high
−12.8%
vs 50-day average
−0.1%
vs 200-day average
+2.3%
Volatility (1 year)
21%
Beta vs S&P 500
0.21

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
7 up, 5 down
typical move ±3.2%
After a week
6 up, 6 down
typical move ±3.8%
After a month
7 up, 5 down
typical move ±4.9%
Results releasedNext dayS&P 500 next day5 days21 days
August 5, 2026 +2.6% −0.4% −2.3% −6.0%
May 6, 2026 −1.5% +1.1% −3.7% −3.8%
February 11, 2026 −5.6% −1.6% −2.8% −5.6%
November 5, 2025 −3.9% −0.7% −0.5% −2.4%
August 6, 2025 −3.3% +0.7% 0.0% +3.9%
May 7, 2025 +3.2% +1.1% +3.7% +3.4%
February 11, 2025 −4.9% −0.2% −4.4% −5.3%
November 6, 2024 +5.0% +3.3% +8.5% +7.1%
August 7, 2024 +3.4% +1.6% +6.4% +6.2%
May 6, 2024 +0.6% +1.1% +2.7% +3.8%
February 14, 2024 +4.1% +1.6% +7.6% +5.3%
November 8, 2023 +0.9% −0.7% +2.6% +6.0%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Primerica, Inc.
$2.6B $2.8B $3B $3.2B $3.4B $3.6B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $2.7B Revenue (TTM), FY23 Q4: $2.7B Revenue (TTM), FY24 Q1: $2.8B Revenue (TTM), FY24 Q2: $2.9B Revenue (TTM), FY24 Q3: $3B Revenue (TTM), FY24 Q4: $3.1B Revenue (TTM), FY25 Q1: $3.2B Revenue (TTM), FY25 Q2: $3.2B Revenue (TTM), FY25 Q3: $3.2B Revenue (TTM), FY25 Q4: $3.3B Revenue (TTM), FY26 Q1: $3.4B Revenue (TTM), FY26 Q2: $3.4B $3.4B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $2.7B
FY23 Q4 $2.7B
FY24 Q1 $2.8B
FY24 Q2 $2.9B
FY24 Q3 $3B
FY24 Q4 $3.1B
FY25 Q1 $3.2B
FY25 Q2 $3.2B
FY25 Q3 $3.2B
FY25 Q4 $3.3B
FY26 Q1 $3.4B
FY26 Q2 $3.4B
Revenue growth, TTM YoY Primerica, Inc.
-5% 0% 5% 10% 15% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -3.3% Revenue growth, TTM YoY, FY23 Q4: 3.4% Revenue growth, TTM YoY, FY24 Q1: 6.7% Revenue growth, TTM YoY, FY24 Q2: 10.9% Revenue growth, TTM YoY, FY24 Q3: 12.8% Revenue growth, TTM YoY, FY24 Q4: 12.4% Revenue growth, TTM YoY, FY25 Q1: 12.3% Revenue growth, TTM YoY, FY25 Q2: 7.8% Revenue growth, TTM YoY, FY25 Q3: 7.3% Revenue growth, TTM YoY, FY25 Q4: 6.6% Revenue growth, TTM YoY, FY26 Q1: 6.4% Revenue growth, TTM YoY, FY26 Q2: 8.6% 8.6%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -3.3%
FY23 Q4 3.4%
FY24 Q1 6.7%
FY24 Q2 10.9%
FY24 Q3 12.8%
FY24 Q4 12.4%
FY25 Q1 12.3%
FY25 Q2 7.8%
FY25 Q3 7.3%
FY25 Q4 6.6%
FY26 Q1 6.4%
FY26 Q2 8.6%
FCF margin (TTM) Primerica, Inc.
23% 24% 25% 26% 27% 28% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 23.4% FCF margin (TTM), FY23 Q4: 24.0% FCF margin (TTM), FY24 Q1: 24.8% FCF margin (TTM), FY24 Q2: 25.1% FCF margin (TTM), FY24 Q3: 26.8% FCF margin (TTM), FY24 Q4: 27.1% FCF margin (TTM), FY25 Q1: 26.2% FCF margin (TTM), FY25 Q2: 25.9% FCF margin (TTM), FY25 Q3: 25.3% FCF margin (TTM), FY25 Q4: 26.8% FCF margin (TTM), FY26 Q1: 25.1% FCF margin (TTM), FY26 Q2: 25.5% 25.5%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 23.4%
FY23 Q4 24.0%
FY24 Q1 24.8%
FY24 Q2 25.1%
FY24 Q3 26.8%
FY24 Q4 27.1%
FY25 Q1 26.2%
FY25 Q2 25.9%
FY25 Q3 25.3%
FY25 Q4 26.8%
FY26 Q1 25.1%
FY26 Q2 25.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 2,220 1,362 1,103 1,154 1,229 1,337 1,404 1,519 1,689 1,900 2,053 2,218 2,710 2,657 2,749 3,089 3,292 3,431
Gross profit — — — — — — — — — — — — 2,657 2,589 2,693 — — —
Net income 495 232 157 174 160 181 190 219 350 324 366 386 477 472 577 471 749 795
Diluted EPS — $3.06 $2.08 $2.71 $2.83 $3.29 $3.70 $4.59 $7.61 $7.33 $8.62 $9.57 $11.99 $12.33 $15.94 $13.71 $22.91 $24.95
Growth (year on year)
Revenue — −38.7% −19.0% +4.6% +6.5% +8.8% +5.0% +8.2% +11.2% +12.5% +8.0% +8.0% +22.2% −1.9% +3.4% +12.4% +6.6% +8.6%
Net income — −53.0% −32.4% +10.6% −7.9% +13.3% +4.7% +15.6% +59.6% −7.5% +13.1% +5.4% +23.6% −1.1% +22.1% −18.4% +59.1% +12.2%
Diluted EPS — — −32.0% +30.3% +4.4% +16.3% +12.5% +24.1% +65.8% −3.7% +17.6% +11.0% +25.3% +2.8% +29.3% −14.0% +67.1% +17.7%
Margins
Gross margin — — — — — — — — — — — — 98.1% 97.4% 98.0% — — —
Net margin 22.3% 17.1% 14.3% 15.1% 13.0% 13.6% 13.5% 14.4% 20.7% 17.1% 17.9% 17.4% 17.6% 17.8% 21.0% 15.2% 22.7% 23.2%
Free-cash-flow margin 32.0% 2.3% 7.6% 10.8% 15.3% 17.7% 18.5% 19.4% 23.2% 25.2% 23.7% 29.0% 24.2% 28.5% 25.2% 27.9% 27.4% —
Cash flow
Cash from operations 716 41 87 124 188 237 259 294 392 478 486 643 657 758 693 862 901 892
Capital spending 5 10 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 —
Free cash flow 711 31 83 124 188 237 259 294 392 478 486 643 657 758 693 862 901 —
Stock-based pay −2 47 18 19 14 18 15 13 15 17 18 19 17 22 19 25 25 25
Free cash flow after stock pay 713 −16 65 105 174 219 244 281 376 461 468 624 640 735 674 837 877 —
Balance sheet
Cash 603 126 136 112 149 192 152 212 280 262 257 548 393 489 594 688 756 600
Total debt 0 0 300 375 — 0 0 0 0 0 0 0 0 0 0 0 0 0
Net debt (negative = net cash) −603 −126 164 263 −149 −192 −152 −212 −280 −262 −257 −548 −393 −489 −594 −688 −756 −600
Diluted shares — 73m 73m 62m 57m 55m 51m 47m 46m 44m 42m 40m 40m 38m 36m 34m 33m 32m
Returned to shareholders
Dividends 0 2 7 15 25 27 33 33 36 44 58 64 75 255 330 290 272 278
Buybacks 0 0 204 258 86 148 200 150 150 210 225 231 19 356 375 425 450 473
Total returned 0 2 211 272 111 174 233 183 186 254 283 296 93 611 705 715 722 752

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

FY2026 Q2 TTM
Buybacks (TTM)
$473M
Dividends (TTM)
$278M
Returned to shareholders
86%
of free cash flow
Buybacks, last 3 fiscal years
$1.3B
Diluted share count
−4.7%
year over year
Total shareholder yield
8.6%
dividends 3.2% + buybacks 5.4% of market value
Dividend payout ratio
35%
of net income paid out

Competitors: side by side with peers

Closest by revenue in life & health insurance
Last 12 months unless stated PRI MFC FG GL JXN BHF Median
Revenue, last 12 months $3.4bn $5.8bn $6.1bn $6.2bn $6.5bn $6.7bn $10.6bn
Revenue growth, last 12 months 8.6% 5.0% 15.0% 5.2% 15.1% 2.6% 7.0%
Revenue growth, 3-year average 9.1% — 19.4% 5.5% 43.4% 37.8% 5.5%
Revenue growth, latest quarter 9.0% — 4.2% 8.0% −22.6% 86.2% 8.0%
Gross margin 98.1% — — 23.8% — — 60.9%
Net margin 23.2% 68.5% 6.9% 19.6% 1.6% 12.5% 6.9%
Cash from operations / revenue 26.0% 394.9% 71.5% 22.5% 90.9% −8.1% 15.8%
Free-cash-flow margin 25.5% 390.5% 59.9% 19.9% 90.9% — 19.7%
Free-cash-flow margin, 3-year average 25.5% 152.8% 86.7% 22.2% 106.8% — 22.2%
Stock pay / revenue 0.7% 0.0% 0.6% 0.9% 1.6% — 0.7%
Change in share count −4.7% −4.3% 2.7% −5.3% −5.8% −2.6% −4.7%

Median of all 19 companies we cover in life & health insurance. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Term Life Insurance Segment Revenues $1.8B 55.3% ▲ 2.9%
Investment and Savings Products Segment Revenues $1.2B 37.9% ▲ 18.1%
Corporate and Other $224M 6.8% ▼ 15.3%
Geography
Region Revenue Share YoY
United States $2.9B 86.6% ▲ 5.8%
Canada $441M 13.4% ▲ 11.6%

From Primerica, Inc.'s 10-K filed February 27, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$8.3B
Institutions reporting
520
Shares held vs prior quarter
▼ 1.8%
Positions opened / closed
62 / 44

Top buyers and sellers, Q2 2026: 247 institutions bought and 223 sold ; the biggest buyer was Arrowstreet Capital, Limited Partnership (+190K shares) and the biggest seller Bank Of Montreal (−507K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $848M 3.0M 10.3% ▼ 0.3%
FMR LLC $802M 2.8M 9.7% ▼ 0.2%
Kayne Anderson Rudnick Investment Management LLC $787M 2.8M 9.5% ▼ 9.9%
Vanguard Portfolio Management LLC $522M 1.8M 6.3% ▲ 0.3%
Vanguard Capital Management LLC $402M 1.4M 4.9% ▼ 1.2%
State Street Corp $296M 1.0M 3.6% ▲ 3.8%
Geode Capital Management, LLC $257M 906K 3.1% ▲ 4.1%
Brave Warrior Advisors, LLC $246M 866K 3.0% ▼ 1.5%
Bank Of Montreal $213M 750K 2.6% ▼ 40.3%
BAMCO Inc $191M 671K 2.3% ▼ 21.9%
Dimensional Fund Advisors LP $188M 661K 2.3% ▲ 1.6%
Fiduciary Management Inc $152M 534K 1.8% ▼ 22.8%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Primerica, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $4.5M 11 trades by 5 insiders · 93% under pre-set plans
Net ▼ $4.5M net selling
Insider Date Trade Shares Price Value
Schneider Peter W. President August 17, 2026 Sell pre-set plan 1,800 $312.65 $562,770
Cottle Amber Lynne Director August 11, 2026 Sell 279 $313.63 $87,503
Williams Glenn J. Chief Executive Officer August 10, 2026 Sell pre-set plan 1,500 $320.20 $480,300
Williams Glenn J. Chief Executive Officer June 12, 2026 Sell pre-set plan 1,500 $280.49 $420,735
Schneider Peter W. President May 18, 2026 Sell pre-set plan 1,800 $279.64 $503,352
Schneider Peter W. President March 10, 2026 Sell pre-set plan 1,800 $252.38 $454,284
Jendusa Nicholas Adam Principal Accounting Officer March 2, 2026 Sell 190 $255.51 $48,547
Williams Glenn J. Chief Executive Officer February 17, 2026 Sell pre-set plan 2,500 $256.41 $641,025
Babbit Joel M. Director December 3, 2025 Sell 700 $255.00 $178,500
Schneider Peter W. President November 17, 2025 Sell pre-set plan 2,000 $255.30 $510,600
Williams Glenn J. Chief Executive Officer November 12, 2025 Sell pre-set plan 2,500 $259.65 $649,125

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 6 trades and filings

No trades in Primerica, Inc. disclosed in the last 12 months; 6 earlier trades on record.

  • Jefferson Shreve(R-IN 6):Sale (full), $15,001 - $50,000, traded May 12, 2025, filed June 22, 2025
  • Jefferson Shreve(R-IN 6):Sale (partial), $15,001 - $50,000, traded February 24, 2025, filed March 9, 2025
  • Thomas MacArthur(NJ):Sale (partial), $1,001 - $15,000, traded October 31, 2018, filed December 6, 2018

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around November 4, 2026 estimated from the company's past filing pattern, not announced

  • August 5, 2026
  • May 6, 2026
  • February 11, 2026
  • November 5, 2025
  • August 6, 2025
  • May 7, 2025

Recent SEC filings

Data status

When each part of this page on Primerica, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Primerica, Inc. in brief

What does Primerica, Inc. do?
Primerica, Inc. is a US-listed company in the life & health insurance industry. Its financial year ends in December.
What is Primerica, Inc.'s stock ticker?
Primerica, Inc. trades under the ticker PRI on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Primerica, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Primerica, Inc. reported revenue of $3.4B, 8.6% higher than a year earlier, according to its SEC filings.
What is Primerica, Inc.'s free cash flow?
Primerica, Inc.'s free-cash-flow margin is 25.5% of revenue over the trailing twelve months.
Who are Primerica, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., FMR LLC and Kayne Anderson Rudnick Investment Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Primerica, Inc. buying back stock, and does it pay a dividend?
Primerica, Inc. spent $473M on share repurchases over the trailing twelve months, and its diluted share count fell 4.7% over the year.
What is Primerica, Inc.'s market cap?
On November 2, 2026, Primerica, Inc.'s market capitalisation was about $9B, with a price-to-earnings ratio of 11.4 and net debt of -$600M. Market figures come from third-party market data and may be delayed.
Does Primerica, Inc. pay a dividend?
Yes: Primerica, Inc. paid $278M in dividends over the trailing twelve months, a dividend yield of 3.18% and a payout ratio of 35.0%.
Who are Primerica, Inc.'s competitors?
In our Life & Health Insurance peer group, the companies closest to Primerica, Inc. are Manulife Financial Corp, F&G Annuities & Life, Inc., Globe Life, Jackson Financial Inc. and Brighthouse Financial, Inc. The side-by-side comparison below sets their revenue, margins and growth against Primerica, Inc.'s.
Are insiders buying or selling Primerica, Inc. stock?
Over the last 12 months, Primerica, Inc.'s directors and officers reported 0 open-market purchases and 11 sales on Form 4. The insider trading page charts every trade.
When is Primerica, Inc.'s next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Primerica, Inc. announces its own schedule.